Stay updated on Bepirovirsen in Chronic Hepatitis B Clinical Trial
Sign up to get notified when there's something new on the Bepirovirsen in Chronic Hepatitis B Clinical Trial page.

Latest updates to the Bepirovirsen in Chronic Hepatitis B Clinical Trial page
- Check4 days agoChange DetectedExpanded location listings for numerous U.S. states and international regions are added and old location blocks removed, with the revision tag updated from v3.3.2 to v3.3.3.SummaryDifference0.8%

- Check12 days agoChange DetectedThe study locations list has been updated, adding numerous new sites across several countries (e.g., Argentina, Australia, Canada, China, South Korea) and removing some previously listed sites; the total number of locations and specific site entries have changed.SummaryDifference0.8%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedLiuchow, China was added to the locations list and Liuzhou, China was removed. The page revision was updated to v3.3.2.SummaryDifference0.0%

- Check40 days agoChange DetectedAdded a new site entry: Tainan, Taiwan, 704, and removed the entry labeled Tainan City, Taiwan, 704.SummaryDifference0.2%

- Check55 days agoChange DetectedNo additions or deletions were detected; the page content remains focused on study details, eligibility criteria, and locations.SummaryDifference0.2%

- Check83 days agoChange DetectedThe page now communicates a funding-related operating-status notice and confirms the center is open, plus a new version identifier v3.2.0, replacing v3.1.0.SummaryDifference2%

Stay in the know with updates to Bepirovirsen in Chronic Hepatitis B Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bepirovirsen in Chronic Hepatitis B Clinical Trial page.